Professor Sanjoy Ketan Paul
Professor Sanjoy Ketan Paul
Professor of Clinical Epidemiology & Biostatistics, University of Melbourne
Verified email at
Cited by
Cited by
10-year follow-up of intensive glucose control in type 2 diabetes
RR Holman, SK Paul, MA Bethel, DR Matthews, HAW Neil
New England journal of medicine 359 (15), 1577-1589, 2008
Intensive glucose control and macrovascular outcomes in type 2 diabetes
FM Turnbull, C Abraira, RJ Anderson, RP Byington, JP Chalmers, ...
Diabetologia 52 (11), 2288-2298, 2009
Long-term follow-up after tight control of blood pressure in type 2 diabetes
RR Holman, SK Paul, MA Bethel, HAW Neil, DR Matthews
New England Journal of Medicine 359 (15), 1565-1576, 2008
Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes
RR Holman, KI Thorne, AJ Farmer, MJ Davies, JF Keenan, S Paul, ...
New England Journal of Medicine 357 (17), 1716-1730, 2007
Three-year efficacy of complex insulin regimens in type 2 diabetes
RR Holman, AJ Farmer, MJ Davies, JC Levy, JL Darbyshire, JF Keenan, ...
New England Journal of Medicine 361 (18), 1736-1747, 2009
DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?
JA Roberts, SK Paul, M Akova, M Bassetti, JJ De Waele, G Dimopoulos, ...
Clinical infectious diseases 58 (8), 1072-1083, 2014
Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study
K Khunti, M Davies, A Majeed, BL Thorsted, ML Wolden, SK Paul
Diabetes care 38 (2), 316-322, 2015
Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype–positive rheumatoid arthritis patients
H Benham, HJ Nel, SC Law, AM Mehdi, S Street, N Ramnoruth, H Pahau, ...
Science translational medicine 7 (290), 290ra87-290ra87, 2015
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo …
RR Holman, RL Coleman, JCN Chan, JL Chiasson, H Feng, J Ge, ...
The lancet Diabetes & endocrinology 5 (11), 877-886, 2017
Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin
K Khunti, A Nikolajsen, BL Thorsted, M Andersen, MJ Davies, SK Paul
Diabetes, Obesity and Metabolism 18 (4), 401-409, 2016
Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes
SK Paul, K Klein, BL Thorsted, ML Wolden, K Khunti
Cardiovascular diabetology 14 (1), 1-10, 2015
Long-term trends in antidiabetes drug usage in the US: real-world evidence in patients newly diagnosed with type 2 diabetes
O Montvida, J Shaw, JJ Atherton, F Stringer, SK Paul
Diabetes care 41 (1), 69-78, 2018
A multicenter randomized trial of continuous versus intermittent β-lactam infusion in severe sepsis
JM Dulhunty, JA Roberts, JS Davis, SAR Webb, R Bellomo, C Gomersall, ...
American journal of respiratory and critical care medicine 192 (11), 1298-1305, 2015
Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and …
JB Green, MA Bethel, SK Paul, A Ring, KD Kaufman, DR Shapiro, ...
American heart journal 166 (6), 983-989. e7, 2013
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An …
MH Abdul-Aziz, J Lipman, M Akova, M Bassetti, JJ De Waele, ...
Journal of Antimicrobial Chemotherapy 71 (1), 196-207, 2016
CHHIPS (Controlling Hypertension and Hypotension Immediately Post-Stroke) pilot trial: rationale and design
CHHIPS Trial Group
Journal of hypertension 23 (3), 649-655, 2005
Efficacy and safety of traditional Chinese medicine for diabetes: a double-blind, randomised, controlled trial
L Ji, X Tong, H Wang, H Tian, H Zhou, L Zhang, Q Li, Y Wang, H Li, M Liu, ...
PloS one 8 (2), e56703, 2013
Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial
K Khunti, M Stone, S Paul, J Baines, L Gisborne, A Farooqi, X Luan, ...
Heart 93 (11), 1398-1405, 2007
Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial
RR Holman, S Paul, A Farmer, L Tucker, IM Stratton, HAW Neil
Diabetologia 52 (1), 50-59, 2009
Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO …
PNA Harris, AY Peleg, J Iredell, PR Ingram, S Miyakis, AJ Stewardson, ...
Trials 16 (1), 1-8, 2015
The system can't perform the operation now. Try again later.
Articles 1–20